Intervention for Iliofemoral Deep Vein Thrombosis and May-Thurner Syndrome

Taufiq Salahuddin; Ehrin J Armstrong

doi:10.1016/j.iccl.2019.11.003

Intervention for Iliofemoral Deep Vein Thrombosis and May-Thurner Syndrome

Interv Cardiol Clin. 2020 Apr;9(2):243-254. doi: 10.1016/j.iccl.2019.11.003. Epub 2020 Jan 30.

Authors

Taufiq Salahuddin¹, Ehrin J Armstrong²

Affiliations

¹ Cardiology Section, Rocky Mountain Regional VA Medical Center, 1700 North Wheeling Street, Aurora, CO 80045, USA.
² Cardiology Section, Rocky Mountain Regional VA Medical Center, 1700 North Wheeling Street, Aurora, CO 80045, USA; Interventional Cardiology, Vascular Laboratory, Rocky Mountain Regional VA, Division of Cardiology, University of Colorado, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: ehrin.armstrong@gmail.com.

PMID: 32147124
DOI: 10.1016/j.iccl.2019.11.003

Abstract

May-Thurner syndrome, also known as iliac vein compression syndrome, may cause symptoms of venous hypertension and is a predisposing factor for the development of iliofemoral deep vein thrombosis (DVT). Iliofemoral DVT is associated with high rates of development of postthrombotic syndrome, a potentially debilitating condition associated with development of symptoms related to venous outflow obstruction and resulting in reduced quality of life. In this Clinics article, we review procedural intervention with catheter-directed thrombolysis and stenting for iliofemoral DVT and iliac vein compression.

Keywords: Catheter-directed thrombolysis (CDT); Iliac vein compression syndrome; Iliofemoral deep vein thrombosis (DVT); May-Thurner syndrome; Proximal deep vein thrombosis; Venous stenting.

Publication types

Review

MeSH terms

Femoral Vein*
Fibrinolytic Agents / therapeutic use*
Humans
Iliac Vein*
May-Thurner Syndrome / therapy*
Thrombolytic Therapy / methods*
Vascular Surgical Procedures / methods*
Venous Thrombosis / therapy*

Substances

Fibrinolytic Agents